Crypto Briefing·
OpenAI acquires biotech startup Orchestra Bio to push into drug development
OpenAI's acquisition could revolutionize drug development, potentially reducing timelines and increasing efficiency in the pharmaceutical industry.
More news
- TokenPostBOJ’s Koeda Calls for More Rate Increases as Prices Climb in Japan
- TokenPostVectorial Secures $3 Million to Expand AI Consumer Testing Platform
- TokenPostMemeCore Rises 12.97% as 57 of 89 Large Crypto Assets Decline
- Bitcoin.com NewsMastercard Begins Rolling Out AI Agent Payments Service With Coinbase, Base
- The BlockCrypto firms, Wall Street push SEC to revise Regulation Crypto Assets as comments close
- TokenPostFive Bitcoin Transfers Total $652.5 Million in Three Hours